To study the effect of Punarnava churna vati in heavy menses in treating Raktapradar

Randomized controlled clinical trial to study the efficacy of Punarnava churna vati in the management of Raktapradar with special reference to Menorrhagia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090102

Enrollment

Registered

2025-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient having excessive but cyclic menses of more than 7 days Hemoglobin should be more than 8gm percent Patient having bleeding in excessive amount that is number of pads used

Exclusion criteria

Exclusion criteria: Non cooperative patient Hemoglobin less than 8gm percent Patient with comorbidities like Diabetes mellitus Thyroidism Hypertension Patient with IUCD inserted USG showing retained products of conception Patient with recent history of dilatation and curettage threatened or spontaneous or incomplete abortion within last 3 months

Design outcomes

Primary

Measure	Time frame
Reduce Raja Praman Rajastrav avadhi Adhodar shoolTimepoint: 8 weeks	—

Secondary

Measure	Time frame
To reduce Strava swaroop generalized weakness Bhrama accompanied with excessive raja stravaTimepoint: 2 menstrual cycles	—

Countries

India

Contacts

Public ContactDr Varsha Suresh Deshmukh

Shree Saptashrungi Ayurved Mahavidyalaya and Hospital Kamalnagar Hirawadi Panchavati Nashik

varshasdeshmukh15@gmail.com9403513983

Outcome results